The Clinical Genomics Market Estimated to Grow at a CAGR of +17% by 2023 – Know About Regional Outlook, Competitive Strategies, Growth Factors Global Forecast to 2023
Clinical Genomics has a proven track record in bringing novel clinical diagnostics to market and is uniquely positioned to transform the paradigm of colorectal cancer surveillance with its minimally invasive two-gene blood test, Now, Clinical Genomics Market driven by growing significance of early disease detection and prevention, rising insistence for precision medicine, increasing application of genetic testing in oncology, and favourable reimbursement scenario related to genetic testing. However, the enormous cost of genetic testing, and social and ethical implications hinders...
View full press release